Synchronous and metachronous neoplasms in gastric cancer patients: A 23-year study

Table 3 Sites of additional synchronous and metachronous cancers in gastric cancer patients n (%)

Site	No. tumors	Metachronous	Synchronous
	n = 62	n = 39	n = 23
Colorectal	17 (27.4)	7 (17.9)	10 (43.5)
Lung	9 (14.5)	5 (12.8)	4 (17.4)
Breast	8 (12.9)	7 (17.9)	1 (4.3)
Prostate	7 (11.3)	4 (10.3)	3 (13.1)
Lymphoma	4 (6.5)	2 (5.1)	2 (8.7)
Skin	4 (6.5)	2 (5.1)	2 (8.7)
Urinary bladder	3 (4.9)	3 (7.7)	-
Kidney	2 (3.2)	1 (2.6)	1 (4.3)
Larynx	2 (3.2)	2 (5.1)	-
Non Hodgkin Lymphoma	2 (3.2)	2 (5.1)	-
Head	1 (1.6)	1 (2.6)	-
Ovary	1 (1.6)	1 (2.6)	-
Pancreas	1 (1.6)	1 (2.6)	-
Uterus	1 (1.6)	1 (2.6)	-